EUVIMEDEUVIMED entdecken
Crossref

Resistance of Environmental Fungi to Azole Drugs that are Used to Treat Fungal Infections Including Coccidioidomycosis

Ahlam Alamamy, Benjamin Whipkey, Victoria Saez, Antje Lauer

American Journal of Undergraduate Research · 12.04.2026 · 23 (1) · 31

DOI: 10.33697/ajur.2026.166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Undergraduate Research, online erschienen am 12.04.2026. Verfasst von Ahlam Alamamy und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing use of fungicides in the agricultural hub of the Central Valley of California to fight plant pathogens has led to concerns about fungal pathogens developing resistance against these agents. The soil environment harbors many opportunistic fungal species that can cause disease in plants, animals, and humans. Among them are Coccidioides spp. known to cause Valley fever, an orphan disease, endemic to the arid regions of the Southwestern U.S. The disease is often misdiagnosed, delaying treatment with antifungal agents in the early stages of the disease, which has led to the dissemination of the disease in many patients. In this study we found and tested a large cache of fungal isolates, identified as members of ten fungal families and obtained from the air of Bakersfield, Kern County, CA. A large percentage showed strong resistance against three different azole drugs, namely fluconazole, itraconazole, and voriconazole, that are used to treat fungal infections including aspergillosis and Valley fever in humans and animals. Especially fluconazole, one of the most commonly used azole drugs prescribed for treatment, showed no or only minimal effect against most fungal isolates, in contrast to posaconazole which strongly reduced fungal mycelium growth of most isolates in azole challenge assays on Sabouraud Dextrose medium. These results were statistically significant. Two-way ANOVA were used to compare the effects of four azole drugs on fungal mycelium growth among members of ten fungal families. The ANOVA revealed a significant difference in efficacy when comparing the impact of individual drugs on fungal mycelium growth, p < 0.05. Post-hoc comparisons showed that posaconazole significantly inhibited fungal growth more than all other azoles (p < 0.05). Members of most fungal families tested showed a high measure of resistance to azole drugs and 20-39% showed even an increased growth in the presence of fluconazole. The results of this study are concerning in times where Valley fever incidence is increasing due to increased soil disturbance and climate change in the Central Valley of California. KEYWORDS: Coccidioidomycosis; Valley fever; agriculture; fungal pathogen; azole drug; drug resistance; antifungal susceptibility; airborne fungal spores; fungal resistance mechanisms; fungicide

Zitieren

APA

Alamamy, A., Whipkey, B., Saez, V., & Lauer, A. (2026). Resistance of Environmental Fungi to Azole Drugs that are Used to Treat Fungal Infections Including Coccidioidomycosis. American Journal of Undergraduate Research, 23(1), 31. https://doi.org/10.33697/ajur.2026.166

Vancouver

Alamamy A, Whipkey B, Saez V, Lauer A. Resistance of Environmental Fungi to Azole Drugs that are Used to Treat Fungal Infections Including Coccidioidomycosis. American Journal of Undergraduate Research. 2026;23(1):31. doi:10.33697/ajur.2026.166

BibTeX
@article{Alamamy2026,
  author = {Alamamy, Ahlam and Whipkey, Benjamin and Saez, Victoria and Lauer, Antje},
  title = {Resistance of Environmental Fungi to Azole Drugs that are Used to Treat Fungal Infections Including Coccidioidomycosis},
  journal = {American Journal of Undergraduate Research},
  year = {2026},
  volume = {23},
  number = {1},
  pages = {31},
  doi = {10.33697/ajur.2026.166}
}
Kostenlos starten →